Drug recall D-0556-2021
Product
Chantix (varenicline) Tablets Starting Pack Contains: 1 Starting Week (0.5 mgx11 tablets) 3 Continuing Weeks (1 mgx42 tablets) Rx only NDC 0069-0471-03 Distributed by Pfizer Labs Division of Pfizer, Inc., NY, NY 10017
Reason for recall
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
Lots and codes
EC5911
Recall details
- Recalling firm
- Cardinal Health Inc., Dublin, OH
- Quantity
- 1040 cartons
- Distribution
- FL, GA, SC
- Type
- Voluntary: Firm initiated
- Recall initiated
- March 15, 2021
- Terminated
- June 17, 2024
Related products
- Chantix – drug information
- NDC 0069-0471 Chantix · · Pfizer Laboratories Div Pfizer Inc
- NDC 0069-0468 Chantix · Varenicline Tartrate .5 mg/1 · Pfizer Laboratories Div Pfizer Inc
- NDC 0069-0469 Chantix · Varenicline Tartrate 1 mg/1 · Pfizer Laboratories Div Pfizer Inc